Get the Stockscreener App
11.27
3.11%
0.34
Certara Inc stock is traded at $11.27, with a volume of 689.01K.
It is up +3.11% in the last 24 hours and up +10.49% over the past month.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.
See More
Previous Close:
$10.93
Open:
$11.02
24h Volume:
689.01K
Relative Volume:
0.54
Market Cap:
$1.78B
Revenue:
$363.55M
Net Income/Loss:
$-78.68M
P/E Ratio:
93.92
EPS:
0.12
Net Cash Flow:
$50.74M
1W Performance:
+18.01%
1M Performance:
+10.49%
6M Performance:
-32.64%
1Y Performance:
-23.23%
1-Day Range:
$10.93
$11.32
1-Week Range:
$9.41
$11.43
52-Week Range:
$9.41
$19.87
Certara Inc Stock (CERT) Company Profile
Name
Certara Inc
Sector
Industry
Phone
(415) 237-8272
Address
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Compare CERT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CERT
Certara Inc
|
11.27 | 1.78B | 363.55M | -78.68M | 50.74M | 0.12 |
|
VEEV
Veeva Systems Inc
|
226.76 | 36.93B | 2.57B | 615.26M | 996.76M | 3.32 |
|
SOLV
Solventum Corp
|
72.48 | 12.43B | 8.26B | 66.00M | 1.17B | 0.00 |
|
TEM
Tempus Ai Inc
|
62.98 | 10.01B | 640.44M | -743.28M | -206.93M | 0.00 |
|
DOCS
Doximity Inc
|
53.39 | 9.94B | 493.63M | 160.55M | 162.20M | 0.55 |
|
HQY
Healthequity Inc
|
102.47 | 8.91B | 1.10B | 105.67M | -197.98M | 0.1475 |
Certara Inc Stock (CERT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-27-24 | Upgrade | UBS | Neutral → Buy |
| Apr-10-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-04-24 | Initiated | JMP Securities | Mkt Perform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | UBS | Neutral |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Aug-22-23 | Downgrade | Jefferies | Buy → Hold |
| Aug-10-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Apr-03-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-08-22 | Initiated | Berenberg | Buy |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-01-22 | Initiated | Piper Sandler | Overweight |
| Jan-11-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Jul-23-21 | Initiated | Robert W. Baird | Outperform |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-06-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jan-05-21 | Initiated | BofA Securities | Buy |
| Jan-05-21 | Initiated | Credit Suisse | Neutral |
| Jan-05-21 | Initiated | Jefferies | Hold |
| Jan-05-21 | Initiated | William Blair | Outperform |
View All
Certara Inc Stock (CERT) Latest News
Advantage Alpha Capital Partners LP Invests $1.88 Million in Certara, Inc. (NASDAQ:CERT) - MarketBeat
Brown Brothers Harriman & Co. Takes Position in Certara, Inc. (NASDAQ:CERT) - MarketBeat
Massachusetts Financial Services Co. MA Has $45.69 Million Holdings in Certara, Inc. (NASDAQ:CERT) - MarketBeat
B. Metzler seel. Sohn & Co. Holding AG Acquires New Stake in Certara, Inc. (NASDAQ:CERT) - MarketBeat
CERT (Certara) Cash-to-Debt : 0.76 (As of Sep. 2024) - GuruFocus.com
CERT (Certara) 5-Year Dividend Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com
CERT (Certara) Current Deferred Taxes Liabilities : $0.0 Mil (As of Sep. 2024) - GuruFocus.com
CERT (Certara) Cyclically Adjusted Book per Share : $0.00 (As of Sep. 2024) - GuruFocus.com
CERT (Certara) Peter Lynch Fair Value : N/A (As of Nov. 21, 2024) - GuruFocus.com
CERT (Certara) GF Score : 78/100 (As of Nov. 21, 2024) - GuruFocus.com
CERT (Certara) Net Income From Continuing Operations : $-31.1 Mil (TTM As of Sep. 2024) - GuruFocus.com
CERT (Certara) 5-Year EBITDA Growth Rate : -0.90% (As of Sep. 2024) - GuruFocus.com
CERT (Certara) Cash Flow from Operations : $54.4 Mil (TTM As of Sep. 2024) - GuruFocus.com
CERT (Certara) Cash Flow from Investing : $-76.3 Mil (TTM As of Sep. 2024) - GuruFocus.com
CERT (Certara) EBITDA : $55.3 Mil (TTM As of Sep. 2024) - GuruFocus.com
CERT (Certara) 50-Day SMA : $10.82 (As of Nov. 20, 2024) - GuruFocus.com
CERT (Certara) Predictability Rank - GuruFocus.com
CERT (Certara) Future 3-5Y EPS without NRI Growth Rate : 11.29 (As of Nov. 20, 2024) - GuruFocus.com
CERT (Certara) Growth Rank : 9 (As of Nov. 20, 2024) - GuruFocus.com
CERT (Certara) Change In Receivables : $-17.3 Mil (TTM As of Sep. 2024) - GuruFocus.com
CERT (Certara) Earnings Yield % : N/A% (As of Nov. 20, 2024) - GuruFocus.com
CERT (Certara) Earnings per Share (Diluted) : $-0.20 (TTM As of Sep. 2024) - GuruFocus.com
CERT (Certara) Cash From Discontinued Investing Activities : $0.0 Mil (TTM As of Sep. 2024) - GuruFocus.com
CERT (Certara) Cyclically Adjusted FCF per Share : $0.00 (As of Sep. 2024) - GuruFocus.com
CERT (Certara) 3-Year Revenue Growth Rate : 6.80% (As of Sep. 2024) - GuruFocus.com
CERT (Certara) Cash Flow from Discontinued Operations : $0.0 Mil (TTM As of Sep. 2024) - GuruFocus.com
CERT (Certara) EBIT per Share : $-0.06 (TTM As of Sep. 2024) - GuruFocus.com
CERT (Certara) Revenue per Share : $2.33 (TTM As of Sep. 2024) - GuruFocus.com
CERT (Certara) 3-Year EBITDA Growth Rate : 3.80% (As of Sep. 2024) - GuruFocus.com
CERT (Certara) Shares Outstanding (EOP) : 160.9 Mil (As of Sep. 2024) - GuruFocus.com
CERT (Certara) Days Inventory : 0.00 (As of Sep. 2024) - GuruFocus.com
CERT (Certara) 3-Year Dividend Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com
CERT (Certara) Profitability Rank : 5 (As of Sep. 2024) - GuruFocus.com
Certara Inc (CERT) Q2 2024 Earnings: EPS of -$0.08 Misses Estima - GuruFocus.com
Certara price target lowered to $12 from $14 at Barclays - MSN
Leerink Partnrs Brokers Cut Earnings Estimates for Certara - MarketBeat
(CERT) Proactive Strategies - Stock Traders Daily
Certara (NASDAQ:CERT) Sets New 52-Week LowShould You Sell? - MarketBeat
Certara stock hits 52-week low at $9.98 amid market challenges - Investing.com
WASATCH ADVISORS LP Expands Stake in Certara Inc - GuruFocus.com
Soft Biotech Funding and Cost-Cutting Dragged Certara (CERT) in Q3 - Insider Monkey
Certara's SWOT analysis: biosimulation firm navigates market shifts - Investing.com India
Certara's SWOT analysis: biosimulation firm navigates market shifts By Investing.com - Investing.com Australia
Certara, Inc. (NASDAQ:CERT) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Certara (NASDAQ:CERT) Announces Earnings Results - MarketBeat
Certara, Inc. (NASDAQ:CERT) Q3 2024 Earnings Call Transcript - Insider Monkey
Forecasting The Future: 4 Analyst Projections For Certara - Benzinga
Certara (NASDAQ:CERT) Given New $12.00 Price Target at Barclays - MarketBeat
Certara Inc (CERT) Q3 2024 Earnings Call Highlights: Strong Reve - GuruFocus.com
Certara Reports Third Quarter 2024 Financial Results - The Manila Times
Certara Inc (CERT) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Certara Inc Stock (CERT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.88%
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):